Literature DB >> 18036573

The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.

Maxwell Afari Gyamfi1, Ivan Damjanov, Samuel French, Yu-Jui Yvonne Wan.   

Abstract

The differences and similarities of the pathogenesis of alcoholic (ASH) and non-alcoholic steatohepatitis (NASH) were examined. Mice (six/group) received one of four Lieber-Decarli liquid diets for 6 weeks: (1) paired-fed control diet; (2) control diet with ethanol (ethanol); (3) paired-fed methionine/choline deficient (MCD) diet; and (4) MCD plus ethanol (combination). Hepatotoxicity, histology, and gene expression changes were examined. Both MCD and ethanol induced macrovesicular steatosis. However, the combination diet produced massive steatosis with minor necrosis and inflammation. MCD and combination diets, but not ethanol, induced serum ALT levels by 1.6- and 10-fold, respectively. MCD diet, but not ethanol, also induced serum alkaline phosphatase levels suggesting bile duct injury. Ethanol increased liver fatty acid binding protein (L-FABP) mRNA and protein levels. In contrast, the combination diet decreased L-FABP mRNA and protein levels and increased hepatic free fatty acid and lipid peroxide levels. Ethanol, but not MCD, reduced hepatic S-adenosylmethionine (SAM) and GSH levels. Hepatic TNFalpha protein levels were increased in all treatment groups, however, IL-6, a hepatoprotective cytokine which promotes liver regeneration was increased in ethanol-fed mice (2-fold), but decreased in the combination diet-treated mice. In addition, the combination diet reduced phosphorylated STAT3 and Bcl-2 levels. While MCD diet might cause bile duct injury and cholestasis, ethanol preferentially interferes with the SAM-GSH oxidative stress pathway. The exacerbated liver injury induced by the combination diet might be explained by reduced L-FABP, increased free fatty acids, oxidative stress, and decreased IL-6 protein levels. The combination diet is an efficient model of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036573      PMCID: PMC2323588          DOI: 10.1016/j.bcp.2007.09.030

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  64 in total

Review 1.  Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis.

Authors:  A M Diehl
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

2.  CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

Authors:  I A Leclercq; G C Farrell; J Field; D R Bell; F J Gonzalez; G R Robertson
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 3.  Methionine synthase. a possible prime site of the ethanolic lesion in liver.

Authors:  Anthony J Barak; Harriet C Beckenhauer; Dean J Tuma
Journal:  Alcohol       Date:  2002-02       Impact factor: 2.405

Review 4.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

Review 5.  Peroxisomal beta-oxidation and steatohepatitis.

Authors:  M S Rao; J K Reddy
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

6.  Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins.

Authors:  Feng Hong; Won-Ho Kim; Zhigang Tian; Barbara Jaruga; Edward Ishac; Xuening Shen; Bin Gao
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

7.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

Authors:  Feng Hong; Barbara Jaruga; Won Ho Kim; Svetlana Radaeva; Osama N El-Assal; Zhigang Tian; Van-Anh Nguyen; Bin Gao
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 8.  Nonalcoholic steatohepatitis.

Authors:  A E Reid
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

9.  Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig.

Authors:  Charles H Halsted; Jesus A Villanueva; Angela M Devlin; Onni Niemelä; Seppo Parkkila; Timothy A Garrow; Lynn M Wallock; Mark K Shigenaga; Stepan Melnyk; S Jill James
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway.

Authors:  Jie Zhou; Yonggong Zhai; Ying Mu; Haibiao Gong; Hirdesh Uppal; David Toma; Songrong Ren; Ronald M Evans; Wen Xie
Journal:  J Biol Chem       Date:  2006-03-23       Impact factor: 5.157

View more
  22 in total

1.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

2.  Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.

Authors:  Xiaoyan Zhang; Sha Li; Yunfeng Zhou; Wen Su; Xiongzhong Ruan; Bing Wang; Feng Zheng; Margaret Warner; Jan-Åke Gustafsson; Youfei Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

3.  ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.

Authors:  Harshica Fernando; Shakuntala Kondraganti; Kamlesh K Bhopale; David E Volk; Muniasamy Neerathilingam; Bhupendra S Kaphalia; Bruce A Luxon; Paul J Boor; G A Shakeel Ansari
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

4.  Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.

Authors:  Jamil A Haque; Ryan S McMahan; Jean S Campbell; Masami Shimizu-Albergine; Angela M Wilson; Dianne Botta; Theo K Bammler; Richard P Beyer; Thomas J Montine; Matthew M Yeh; Terrance J Kavanagh; Nelson Fausto
Journal:  Lab Invest       Date:  2010-06-14       Impact factor: 5.662

5.  Mechanism for prevention of alcohol-induced liver injury by dietary methyl donors.

Authors:  Christine L Powell; Blair U Bradford; Christopher Patrick Craig; Masato Tsuchiya; Takeki Uehara; Thomas M O'Connell; Igor P Pogribny; Stepan Melnyk; Dennis R Koop; Lisa Bleyle; David W Threadgill; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2010-01-29       Impact factor: 4.849

6.  Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.

Authors:  Maxwell Afari Gyamfi; Yuji Tanaka; Lin He; Curtis D Klaassen; Yu-Jui Yvonne Wan
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-08       Impact factor: 4.219

7.  Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease.

Authors:  Blair U Bradford; Thomas M O'Connell; Jun Han; Oksana Kosyk; Svitlana Shymonyak; Pamela K Ross; Jason Winnike; Hiroshi Kono; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-12       Impact factor: 4.219

Review 8.  Molecular basis and current treatment for alcoholic liver disease.

Authors:  Alejandra Miranda-Mendez; Alejandro Lugo-Baruqui; Juan Armendariz-Borunda
Journal:  Int J Environ Res Public Health       Date:  2010-04-27       Impact factor: 3.390

9.  Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity.

Authors:  Jing Yan; Yuewen Gong; Yi-Min She; Guqi Wang; Michael S Roberts; Frank J Burczynski
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

10.  IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.

Authors:  Emmanuel Mas; Marie Danjoux; Virginie Garcia; Stéphane Carpentier; Bruno Ségui; Thierry Levade
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.